(CLIFTON, NJ) Cantel Medical Corp. has announced that its MediVators, Inc. subsidiary has been granted permission form the FDA to market Rapicide. Rapicide is a high-level disinfectant and sterilant with label claims for a 5 minute 35 degrees Celsius contact time to achieve the high level disinfection of flexible endoscopes in automated endoscope preprocessors. The company says that Rapicide has a reuse life of 28 days which will double the 14 day restriction currently placed on many other products. For more information visit www.cantelmedical.com.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.